SELECT MEDICAL (SEM) STOCK NOTICE: Does $16.50 Per Share Represent a Fair Buyout Price for Select Medical Shareholders? Kaskela Law Firm is Investigating the Fairness of the Buyout Price and Encourages SEM Shareholders to Exercise their Legal Rights and

PHILADELPHIA, PA / ACCESS Newswire / March 7, 2026 / Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. ("Select Medical") (NYSE:SEM) shareholders to determine whether the $16.50 per share buyout price provides investors with sufficient cash for their shares.

Click here for additional information: https://kaskelalaw.com/case/select-medical/

On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a price of $16.50 per share  in cash.  Following the closing of the proposed transaction, SEM shareholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their SEM shares. Notably, at the time the proposed transaction was announced, at least one stock analyst was maintaining a price target for Select Medical's shares of $19.00 per share .

The investigation seeks to determine whether investors will be receiving sufficient financial consideration for their Select Medical shares, and whether the company's representatives breached their fiduciary duties in agreeing to the $16.50 per share buyout price.

Select Medical investors who would like to learn more about the investigation and their legal rights and options are encouraged to contact lead investigative attorney Adrienne Bell, Esq. at (484) 229 - 0750 or by email at [email protected].  You can also click on the following link (or copy and paste it into your browser) to request more information:

https://kaskelalaw.com/case/select-medical/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation.  For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

KASKELA LAW LLC

D. Seamus Kaskela, Esq.

( [email protected] )

Adrienne Bell, Esq.

( [email protected] )

18 Campus Blvd., Suite 100

Newtown Square, PA 19073

(484) 229 - 0750

www.kaskelalaw.com

This communication may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC